CleanSpace Holdings Limited (CSX.AX)
AUD 0.42
(13.51%)
AUD 0.42
(13.51%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 3.44 Million AUD | -13.87% |
| 2023 | 4 Million AUD | -3.14% |
| 2022 | 4.13 Million AUD | -5.75% |
| 2021 | 4.38 Million AUD | 82.61% |
| 2020 | 2.4 Million AUD | 2.72% |
| 2019 | 2.33 Million AUD | -0.17% |
| 2018 | 2.34 Million AUD | 4.36% |
| 2017 | 2.24 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 3.18 Million AUD | -22.82% |
| 2024 Q4 | 3.44 Million AUD | 24.57% |
| 2024 FY | 3.44 Million AUD | -13.87% |
| 2024 Q3 | 2.76 Million AUD | -25.16% |
| 2024 Q2 | 3.69 Million AUD | 15.94% |
| 2023 Q4 | 4.13 Million AUD | 17.41% |
| 2023 Q2 | 4 Million AUD | 12.96% |
| 2023 FY | 4 Million AUD | -3.14% |
| 2023 Q1 | 3.54 Million AUD | -14.21% |
| 2023 Q3 | 3.51 Million AUD | -12.11% |
| 2022 Q4 | 4.13 Million AUD | 11.88% |
| 2022 Q3 | 3.69 Million AUD | -12.49% |
| 2022 Q2 | 4.21 Million AUD | 11.12% |
| 2022 Q1 | 3.79 Million AUD | -13.36% |
| 2022 FY | 4.13 Million AUD | -5.75% |
| 2021 Q1 | 4.16 Million AUD | -14.13% |
| 2021 FY | 4.38 Million AUD | 82.61% |
| 2021 Q2 | 4.6 Million AUD | 10.33% |
| 2021 Q4 | 4.38 Million AUD | 10.27% |
| 2021 Q3 | 3.97 Million AUD | -13.6% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 Q3 | 4.72 Million AUD | 0.0% |
| 2020 Q4 | 4.85 Million AUD | 2.78% |
| 2020 FY | 2.4 Million AUD | 2.72% |
| 2019 FY | 2.33 Million AUD | -0.17% |
| 2018 FY | 2.34 Million AUD | 4.36% |
| 2017 FY | 2.24 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 32.697% |
| Adherium Limited | 93.2 Thousand AUD | -3597.548% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 49.444% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -3970.273% |
| Anteris Technologies Ltd | 2.33 Million AUD | -47.726% |
| Control Bionics Limited | 961.73 Thousand AUD | -258.341% |
| CardieX Limited | 3.22 Million AUD | -6.771% |
| Compumedics Limited | 6.97 Million AUD | 50.605% |
| Cochlear Limited | 243.7 Million AUD | 98.586% |
| Cyclopharm Limited | 4.22 Million AUD | 18.475% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | -18.825% |
| Nova Eye Medical Limited | 3.34 Million AUD | -2.905% |
| HeraMED Limited | 260.65 Thousand AUD | -1222.164% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 78.051% |
| ImpediMed Limited | 1.14 Million AUD | -201.514% |
| InhaleRx Limited | 560.27 Thousand AUD | -515.109% |
| LBT Innovations Limited | 1.74 Million AUD | -97.722% |
| Micro-X Limited | 4.05 Million AUD | 15.011% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -4776.472% |
| PolyNovo Limited | 15.38 Million AUD | 77.592% |
| Respiri Limited | 1.17 Million AUD | -192.912% |
| SomnoMed Limited | 1.01 Million AUD | -239.198% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 30.679% |
| Uscom Limited | 989.27 Thousand AUD | -248.365% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -1004.031% |